NO20030412L - Preparat med vaskul¶r beskyttende og anti-oksidativ virkning og bruken derav - Google Patents

Preparat med vaskul¶r beskyttende og anti-oksidativ virkning og bruken derav

Info

Publication number
NO20030412L
NO20030412L NO20030412A NO20030412A NO20030412L NO 20030412 L NO20030412 L NO 20030412L NO 20030412 A NO20030412 A NO 20030412A NO 20030412 A NO20030412 A NO 20030412A NO 20030412 L NO20030412 L NO 20030412L
Authority
NO
Norway
Prior art keywords
preparation
oxidative effect
vascular protective
vascular
protective
Prior art date
Application number
NO20030412A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030412D0 (no
Inventor
Erich Elstner
Original Assignee
Steigerwald Arzneimittelwerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk filed Critical Steigerwald Arzneimittelwerk
Publication of NO20030412D0 publication Critical patent/NO20030412D0/no
Publication of NO20030412L publication Critical patent/NO20030412L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
NO20030412A 2000-07-28 2003-01-27 Preparat med vaskul¶r beskyttende og anti-oksidativ virkning og bruken derav NO20030412L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10038640A DE10038640A1 (de) 2000-07-28 2000-07-28 Präparat mit gefäßschützender und antioxidativer Wirkung sowie dessen Verwendung
PCT/DE2001/002082 WO2002009685A1 (de) 2000-07-28 2001-05-28 Präparat mit gefässschützender und antioxidativer wirkung sowie dessen verwendung

Publications (2)

Publication Number Publication Date
NO20030412D0 NO20030412D0 (no) 2003-01-27
NO20030412L true NO20030412L (no) 2003-02-11

Family

ID=7651698

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030412A NO20030412L (no) 2000-07-28 2003-01-27 Preparat med vaskul¶r beskyttende og anti-oksidativ virkning og bruken derav

Country Status (18)

Country Link
US (1) US20040047922A1 (de)
EP (1) EP1305013A1 (de)
JP (1) JP2004513077A (de)
CN (1) CN1444475A (de)
AU (1) AU2001267324A1 (de)
BR (1) BR0112663A (de)
CA (1) CA2411907A1 (de)
CZ (1) CZ2003194A3 (de)
DE (2) DE10038640A1 (de)
EE (1) EE200300044A (de)
MX (1) MXPA03000718A (de)
NO (1) NO20030412L (de)
NZ (1) NZ523185A (de)
PL (1) PL364992A1 (de)
RU (1) RU2003105695A (de)
SK (1) SK872003A3 (de)
WO (1) WO2002009685A1 (de)
ZA (1) ZA200210123B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6616942B1 (en) 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
WO2003041632A2 (en) 2001-11-14 2003-05-22 Texas Tech University Eutectic-based self-nanoemulsified drug delivery system
CN1809384A (zh) * 2003-06-25 2006-07-26 C·欧文 提高辅酶q10传送的化学组合物及方法
US20080089877A1 (en) * 2003-08-14 2008-04-17 Udell Ronald G Super Absorption Coenzyme Q10
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
AU2004277951B2 (en) * 2003-09-29 2010-11-11 Soft Gel Technologies, Inc. Solubilized CoQ-10
US7169385B2 (en) * 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
US8343541B2 (en) * 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1343561A (en) * 1972-03-23 1974-01-10 Hisamitsu Pharmaceutical Co Substances for use in the treatment of gallstones
US4246287A (en) * 1979-10-26 1981-01-20 International Flavors & Fragrances Inc. Flavoring with fenchyl ethyl ether
JPS60172925A (ja) * 1984-02-17 1985-09-06 Kao Corp 胆石溶解剤
JPS60204722A (ja) * 1984-03-28 1985-10-16 Junichi Iwamura 高脂血症改善・予防剤
DE69107056D1 (de) * 1990-11-14 1995-03-09 Oreal Amphiphile, nichtionische derivate des glycerins sowie die entsprechenden zwischenprodukte, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
AU659625B2 (en) * 1991-01-18 1995-05-25 Clilco, Ltd. Lice-repellant compositions
JPH08275728A (ja) * 1995-04-06 1996-10-22 New Aqua Gijutsu Kenkyusho:Kk Ｄｈａ油を主成分とする食用油
US5891465A (en) * 1996-05-14 1999-04-06 Biozone Laboratories, Inc. Delivery of biologically active material in a liposomal formulation for administration into the mouth
JP2001511153A (ja) * 1997-02-04 2001-08-07 ブイ． コスバブ，ジョン 血管変性性疾患の予防および処置のための組成物および方法
US5925335A (en) * 1997-06-12 1999-07-20 C.S. Bioscience Inc. Dental formulation
DE19915102A1 (de) * 1999-04-01 2000-10-05 Pohl Boskamp Gmbh Chem Pharma Verwendung von Limonen zur Behandlung oxidativer Zellschädigungen
US20020048551A1 (en) * 1999-04-06 2002-04-25 Keller Brian C. Delivery of biologically active material in a liposomal formulation for administration into the mouth

Also Published As

Publication number Publication date
RU2003105695A (ru) 2004-06-27
NO20030412D0 (no) 2003-01-27
AU2001267324A1 (en) 2002-02-13
EE200300044A (et) 2004-10-15
NZ523185A (en) 2005-07-29
CN1444475A (zh) 2003-09-24
BR0112663A (pt) 2003-06-24
DE10038640A1 (de) 2002-02-14
EP1305013A1 (de) 2003-05-02
MXPA03000718A (es) 2003-06-04
CA2411907A1 (en) 2002-12-05
CZ2003194A3 (cs) 2003-05-14
DE10192998D2 (de) 2003-01-16
SK872003A3 (en) 2003-06-03
JP2004513077A (ja) 2004-04-30
PL364992A1 (en) 2004-12-27
ZA200210123B (en) 2003-05-27
WO2002009685A1 (de) 2002-02-07
US20040047922A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
IS6411A (is) Kaspasa tálmar og notkun þeirra
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
DK1242095T3 (da) Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
EE200100373A (et) Bensoheterotsüklid ja nende kasutamine MEK inhibiitoritena
ID26056A (id) Popok sekali pakai
DK1233964T3 (da) Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
ID26389A (id) Popok sekali pakai
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
NO20034159D0 (no) Östrogen-gestagen-kombinasjonspreparat og anvendelse derav
NO20014603L (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
NO20024810L (no) Dermatologisk preparat samt anvendelse derav
ID25571A (id) Popok sekali pakai
NO20030412D0 (no) Preparat med vaskul¶r beskyttende og anti-oksidativ virkning og bruken derav
IS7275A (is) Samsetning fyrir hollegg og notkun á henni
NO20030156D0 (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
NO20030547D0 (no) Azabicykliske derivater og deres terapeutiske anvendelse
ID29706A (id) Artikel kesehatan sekali pakai
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
NO20001782L (no) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application